Pulse Biosciences, Inc. (PLSE)

NASDAQ: PLSE · Real-Time Price · USD

53.29

+0.22 (0.41%)

At close: Nov 6, 2026, 4:00 PM EST

52.49

-0.80 (-1.50%)

After-hours: Nov 6, 2026, 7:30 PM EST

Pulse Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	36.73	80.74	118.04	44.37	61.14	28.61
Short-Term Investments	152.47	-	-	-	-	-
Cash & Short-Term Investments	189.19	80.74	118.04	44.37	61.14	28.61
Cash Growth	98.70%	-31.60%	166.06%	-27.44%	113.67%	39.75%
Receivables	0.3	0.27	-	-	-	0.06
Inventory	0.23	0.14	-	-	-	5.82
Prepaid Expenses	2.49	2.28	1.41	0.96	1.01	2.13
Total Current Assets	192.21	83.42	119.45	45.33	62.15	36.63
Property, Plant & Equipment	6.13	7.06	8.32	8.78	10.02	11.25
Goodwill	2.79	2.79	2.79	2.79	2.79	2.79
Other Intangible Assets	0.06	0.58	1.22	1.89	2.55	3.22
Other Long-Term Assets	0.4	0.69	0.68	0.37	0.37	0.37
Total Assets	201.58	94.54	132.46	59.15	77.88	54.25

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.02	2.78	1.67	1.84	1.57	2.9
Accrued Expenses	8.63	3.58	5.83	3.81	2.55	3.78
Short-Term Debt	-	-	-	-	-	0.44
Current Portion of Long-Term Debt	-	-	-	-	0.92	-
Current Portion of Leases	1.75	1.57	1.36	1.06	0.9	0.77
Current Unearned Revenue	-	-	-	-	-	0.02
Other Current Liabilities	-	-	1.2	-	0.05	0.61
Total Current Liabilities	13.4	7.92	10.06	6.71	5.98	8.52
Long-Term Debt	-	-	-	-	65	-
Long-Term Leases	4.62	5.96	7.54	8.09	9.14	10.04
Total Liabilities	18.01	13.88	17.6	14.79	80.13	18.56

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.07	0.07	0.07	0.06	0.04	0.03
Additional Paid-In Capital	713.15	543.87	505.3	381.22	292.42	271.86
Retained Earnings	-529.57	-463.28	-390.5	-336.92	-294.71	-236.2
Comprehensive Income & Other	-0.08	-	-	-	-	-
Shareholders' Equity	183.57	80.66	114.86	44.36	-2.25	35.69
Total Liabilities & Equity	201.58	94.54	132.46	59.15	77.88	54.25

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	6.36	7.53	8.9	9.14	75.96	11.25
Net Cash (Debt)	182.83	73.21	109.14	35.22	-14.82	17.36
Net Cash Growth	109.37%	-32.93%	209.87%	-	-	90.42%
Net Cash Per Share	2.64	1.09	1.87	0.71	-0.44	0.62
Filing Date Shares Outstanding	73.55	67.99	67.27	55.23	37.59	29.8
Total Common Shares Outstanding	73.31	67.84	65.93	55.14	37.24	29.72
Working Capital	178.81	75.5	109.39	38.62	56.17	28.11
Book Value Per Share	2.50	1.19	1.74	0.80	-0.06	1.20
Tangible Book Value	180.73	77.29	110.85	39.68	-7.59	29.68
Tangible Book Value Per Share	2.47	1.14	1.68	0.72	-0.20	1.00
Machinery	-	2.61	2.31	2.21	2.08	1.95
Construction In Progress	-	0.01	0.03	-	0.02	0.19
Leasehold Improvements	-	2.52	2.52	2.52	2.52	2.52

SEC Filings: 10-K · 10-Q